Cargando…
Progress in 3D Bioprinting Technology for Osteochondral Regeneration
Osteochondral injuries can lead to osteoarthritis (OA). OA is characterized by the progressive degradation of the cartilage tissue together with bone tissue turnover. Consequently, joint pain, inflammation, and stiffness are common, with joint immobility and dysfunction being the most severe symptom...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414312/ https://www.ncbi.nlm.nih.gov/pubmed/36015207 http://dx.doi.org/10.3390/pharmaceutics14081578 |
_version_ | 1784775957847998464 |
---|---|
author | Lafuente-Merchan, Markel Ruiz-Alonso, Sandra García-Villén, Fátima Gallego, Idoia Gálvez-Martín, Patricia Saenz-del-Burgo, Laura Pedraz, Jose Luis |
author_facet | Lafuente-Merchan, Markel Ruiz-Alonso, Sandra García-Villén, Fátima Gallego, Idoia Gálvez-Martín, Patricia Saenz-del-Burgo, Laura Pedraz, Jose Luis |
author_sort | Lafuente-Merchan, Markel |
collection | PubMed |
description | Osteochondral injuries can lead to osteoarthritis (OA). OA is characterized by the progressive degradation of the cartilage tissue together with bone tissue turnover. Consequently, joint pain, inflammation, and stiffness are common, with joint immobility and dysfunction being the most severe symptoms. The increase in the age of the population, along with the increase in risk factors such as obesity, has led OA to the forefront of disabling diseases. In addition, it not only has an increasing prevalence, but is also an economic burden for health systems. Current treatments are focused on relieving pain and inflammation, but they become ineffective as the disease progresses. Therefore, new therapeutic approaches, such as tissue engineering and 3D bioprinting, have emerged. In this review, the advantages of using 3D bioprinting techniques for osteochondral regeneration are described. Furthermore, the biomaterials, cell types, and active molecules that are commonly used for these purposes are indicated. Finally, the most recent promising results for the regeneration of cartilage, bone, and/or the osteochondral unit through 3D bioprinting technologies are considered, as this could be a feasible therapeutic approach to the treatment of OA. |
format | Online Article Text |
id | pubmed-9414312 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94143122022-08-27 Progress in 3D Bioprinting Technology for Osteochondral Regeneration Lafuente-Merchan, Markel Ruiz-Alonso, Sandra García-Villén, Fátima Gallego, Idoia Gálvez-Martín, Patricia Saenz-del-Burgo, Laura Pedraz, Jose Luis Pharmaceutics Review Osteochondral injuries can lead to osteoarthritis (OA). OA is characterized by the progressive degradation of the cartilage tissue together with bone tissue turnover. Consequently, joint pain, inflammation, and stiffness are common, with joint immobility and dysfunction being the most severe symptoms. The increase in the age of the population, along with the increase in risk factors such as obesity, has led OA to the forefront of disabling diseases. In addition, it not only has an increasing prevalence, but is also an economic burden for health systems. Current treatments are focused on relieving pain and inflammation, but they become ineffective as the disease progresses. Therefore, new therapeutic approaches, such as tissue engineering and 3D bioprinting, have emerged. In this review, the advantages of using 3D bioprinting techniques for osteochondral regeneration are described. Furthermore, the biomaterials, cell types, and active molecules that are commonly used for these purposes are indicated. Finally, the most recent promising results for the regeneration of cartilage, bone, and/or the osteochondral unit through 3D bioprinting technologies are considered, as this could be a feasible therapeutic approach to the treatment of OA. MDPI 2022-07-29 /pmc/articles/PMC9414312/ /pubmed/36015207 http://dx.doi.org/10.3390/pharmaceutics14081578 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Lafuente-Merchan, Markel Ruiz-Alonso, Sandra García-Villén, Fátima Gallego, Idoia Gálvez-Martín, Patricia Saenz-del-Burgo, Laura Pedraz, Jose Luis Progress in 3D Bioprinting Technology for Osteochondral Regeneration |
title | Progress in 3D Bioprinting Technology for Osteochondral Regeneration |
title_full | Progress in 3D Bioprinting Technology for Osteochondral Regeneration |
title_fullStr | Progress in 3D Bioprinting Technology for Osteochondral Regeneration |
title_full_unstemmed | Progress in 3D Bioprinting Technology for Osteochondral Regeneration |
title_short | Progress in 3D Bioprinting Technology for Osteochondral Regeneration |
title_sort | progress in 3d bioprinting technology for osteochondral regeneration |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414312/ https://www.ncbi.nlm.nih.gov/pubmed/36015207 http://dx.doi.org/10.3390/pharmaceutics14081578 |
work_keys_str_mv | AT lafuentemerchanmarkel progressin3dbioprintingtechnologyforosteochondralregeneration AT ruizalonsosandra progressin3dbioprintingtechnologyforosteochondralregeneration AT garciavillenfatima progressin3dbioprintingtechnologyforosteochondralregeneration AT gallegoidoia progressin3dbioprintingtechnologyforosteochondralregeneration AT galvezmartinpatricia progressin3dbioprintingtechnologyforosteochondralregeneration AT saenzdelburgolaura progressin3dbioprintingtechnologyforosteochondralregeneration AT pedrazjoseluis progressin3dbioprintingtechnologyforosteochondralregeneration |